About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.99 (+6.79%)
UPB NASDAQ Upstream Bio, Inc.
Upstream Bio, Inc. share price
Atividade de preço de UPB
Último preço
$ 2,990
Variação (24h)
0,19 USD (6,79%)
Volume
1.45M
Volume (média 4 sem.)
-
Abertura
$ 2,77
Variação do dia
$ 2,70 - $ 2,99
Fechamento anterior
$ 2,80
Último negócio
22 Oct, 8:14 pm GMT+0
Atrasado
22 Oct, 8:14 pm GMT+0
UPB price performance
Atrasado
22 Oct, 8:14 pm GMT+0
quote.marketSignals